HIV/AIDS HAART
HIV-1 protease inhibitor-associated mutation prevalence correlates with long-term treatment
Published in AIDS Weekly, September 11th, 2006
"Treatment of human immunodeficiency virus type I with protease inhibitors (PIs) is associated with the emergence of resistance-associated mutations. Treatment-characterized datasets have been used to identify novel treatment-associated protease mutations," wrote investigators in the United States.
According to R.M. Kagan and colleagues at Quest Diagnostic Nichols Institute, "In this study, we utilized two large reference laboratory databases (>11,5000 viral sequences) to identify nonestablished...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2006-09-11)
More Articles from AIDS Weekly
- HIV/AIDS Diet & Nutrition
HIV-infected patients deficient in vitamin D - HIV/AIDS Drug Development
Antifungal protein isolated from the pea inhibits HIV-1 reverse transcriptase - HIV/AIDS HAART
Atazanavir clearance increases when used in combination with certain antiretrovirals - HIV/AIDS Pathogenesis
Antibody maturation not seriously disrupted in germinal centers during early HIV infection - Business & Finance
Chembio reports net product sales increase 93% compared to second quarter of 2005 - Business & Finance
Lipid Sciences, Inc., reports Q2 net loss of $2.6 million - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
